期刊档案 · 医学-肿瘤学
Seminars in Oncology
ISSN 0093-7754 · eISSN 1532-8708 · W.B. Saunders Ltd · UNITED STATES · Bimonthly · 创刊 1974
Seminars in Oncology 中科院 医学 4区(2025 年升级版),影响因子 6.61,混合开放获取,APC 约 3,550 美元,近 24 个月 102 篇文章投稿到接收中位 100 天,录用比例一般(社区反馈),2025 年发文 96 篇,SCIE、Scopus 收录。
研究范围
研究范围与定位
Seminars in Oncology 由 W.B. Saunders Ltd 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Cancer Treatment and Pharmacology、Lung Cancer Treatments and Mutations、Diverse Scientific and Economic Studies 等主题的论文,这 3 个主题约占 21%,主导子领域为 Oncology。(根据 OpenAlex 主题统计与中科院分区数据生成)
Seminars in Oncology brings you current, authoritative, and practical articles on advances in the etiology, diagnosis and management of cancer. The journal is dedicated to providing both the basic knowledge needed to better understand cancer-related subjects as well as evidence-based perspectives from leaders in the field. Seminars in Oncology also seeks to be a venue for sharing diverse viewpoints, including innovative and unconventional ideas that might be considered "outside the box". We encourage a healthy, constructive and respectful exchange of opinions and welcome your insights as well as suggestions for topics worthy of coverage. By deepening readers understand of the basic biology and therapy of cancer through expert insights, and by fostering an open exchange of ideas, Seminars in Oncology aims to advance the science and practice of cancer care.
摘自期刊官网 Aims & Scope
研究方向(LetPub):医学-肿瘤学
主编 Yuqing Zhang出版商官网
编委会国家分布:中国大陆 5 位(约 31%);主要国家 美国 11、中国 5(共 16 位编委标注了国家) 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Cancer Treatment and PharmacologyMedicine7.2%
- Lung Cancer Treatments and MutationsMedicine7.1%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.7%
- Colorectal Cancer Treatments and StudiesMedicine5.6%
- HER2/EGFR in Cancer ResearchMedicine5.2%
- Lung Cancer Research StudiesMedicine5%
- Human auditory perception and evaluationEngineering4.8%
- Lymphoma Diagnosis and TreatmentMedicine4.7%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 肿瘤学ONCOLOGY | 4 区 |
Top 期刊:否综述期刊:是
《新锐期刊分区表》( 2026年3月发布)医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 肿瘤学ONCOLOGY | 4 区 |
Top 期刊:否综述期刊:未标注
期刊分区表( 2023年12月旧的升级版)医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 肿瘤学ONCOLOGY | 4 区 |
Top 期刊:否综述期刊:是
数据库收录
SCIEScopusLetPub
国际期刊预警名单:各版本均未列入LetPub
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 6.61LetPub ·
- 影响因子(出版商公布)
- 6.8出版商官网 ·
- CiteScore 2026-06
- 4.9LetPub ·
- CiteScore(出版商公布)
- 4.9出版商官网 ·
- SJR 2026-06
- 1.54LetPub ·
- SNIP 2026-06
- 1.09LetPub ·
- h-index
- 125LetPub ·
- h-index
- 149OpenAlex ·
- i10-index
- 2,137OpenAlex ·
- 两年平均被引
- 2.84OpenAlex ·
- 自引率
- 8.8%LetPub ·
- Gold OA 文章占比
- 19.47%LetPub ·
发文规模
- 年文章数
- 75LetPub ·
逐年发文量 OpenAlex 统计 · 累计 4,240 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 62 | 18 | 16 |
| 2025 | 96 | 17 | 387 |
| 2024 | 31 | 10 | 133 |
| 2023 | 38 | 10 | 437 |
| 2022 | 78 | 17 | 603 |
| 2021 | 52 | 21 | 1,021 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
100 天投稿到接收中位数 · P25–P75 68 天 – 144 天
- 接收到上线
- 中位数 9 天(102 篇)
- 投稿到上线
- 中位数 124 天
- 样本
- 102 篇有投稿与接收日期的文章(窗口内共 125 篇),最近一篇接收于
只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度(社区反馈)
- 较慢,6-12周LetPub ·
- 平均录用比例(社区反馈)
- 一般LetPub ·
- 投稿到首次决定
- 1 天出版商官网 ·
- 外审后首次决定
- 36 天出版商官网 ·
- 投稿到接收
- 86 天出版商官网 ·
- 接收到发表
- 33 天出版商官网 ·
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
订阅期刊,作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 3,550 / EUR 3,320 / GBP 2,840 / JPY 440,310 | — | — | |
| 出版商官网 | USD 3,900 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取;按订阅方式发表通常不收费。
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点3 项,摘自作者指南
- 摘要
- ≤ 250 词
- 正文篇幅
- ≤ 6,000 词
- 参考文献格式
- 顺序编码制(按引用顺序编号)
接收的文章类型14 种,含篇幅限制
- case reportReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…正文 ≤ 3,000 词
- case reportsCase Reports are peer reviewed, limited to 3,000 words, and may include up to five display items (figures, tables, or videos).未说明篇幅
- consensus statements and guidelinesGuidelines and Consensuses Statements are peer-reviewed. Submissions should contain a maximum of 6,000 words (excluding the abstract, references, figures, and t…未说明篇幅
- letters to the editorReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…未说明篇幅
- mini reviewmay include up to 6 figures and tables. Mini Reviews Mini reviews should have 3000-3500 words, with appropriate reductions for one or two figures or tabl正文 ≤ 3,500 词
- mini reviewsMini reviews should have 3000-3500 words, with appropriate reductions for one or two figures or tables, and should include a brief abstract, an introduction, a …未说明篇幅
- original articleReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…未说明篇幅
- original research articleReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…未说明篇幅
- perspectiveReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…未说明篇幅
- research articlesHigh-quality original research articles related to the latest trends and advances, covering all aspects of oncology and cancer research. The maximum text amount…未说明篇幅
- reviewReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…正文 ≤ 6,000 词
- review articlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excluding reference…未说明篇幅
- short communicationuires an abstract maximum of 350 words. Short Communications Short communications should not exceed 3000 words excluding references; they may contain up to 3 fi…正文 ≤ 3,000 词
- short communicationsShort communications should not exceed 3000 words excluding references; they may contain up to 3 figures or tables.未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、预印本
- AI 使用 Declaration of generative AI use
作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Group authorship
集体署名指将文章归属于一个明确且具名的作者群体,须在投稿时于标题页声明。 模型中文摘要
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
原文 ↗出版商官网 ·- 利益冲突 Declaration of competing interests
所有作者必须披露可能不当影响或偏倚其工作的与他人或组织的财务和个人关系。 模型中文摘要
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
原文 ↗出版商官网 ·- 许可与版权 License options
作者将获得开放获取用户许可选项,建议在选择许可前审查这些选项及资助机构的许可要求。 模型中文摘要
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
原文 ↗出版商官网 ·- 开放获取 Open access
本刊开放获取选项请参阅开放获取信息页面。 模型中文摘要
We refer you to our open access information page to learn about open access options for this journal.
原文 ↗出版商官网 ·- 同行评审 Peer review
本刊采用单盲同行评审,稿件通常由至少两名审稿人独立评审,录用与否由编辑决定。 模型中文摘要
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
原文 ↗出版商官网 ·- 预印本 Preprints
作者可按照Elsevier文章共享政策分享预印本,分享预印本不计作先前发表。 模型中文摘要
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- W.B. Saunders Ltd
- 出版国家或地区
- UNITED STATES
- 出版语言
- English
- 出版周期
- Bimonthly
- 创刊年份
- 1974
- ISSN
- 0093-7754
- 电子版 ISSN
- 1532-8708
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗出版商官网
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Seminars in Oncology 的常见问题
Seminars in Oncology 是中科院几区期刊?
2025 年升级版分区表中,Seminars in Oncology 为医学 4区,小类 肿瘤学 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Seminars in Oncology 的影响因子是多少?
LetPub 汇总的最新公布影响因子为 6.61,CiteScore 为 4.9,h-index 为 149。
Seminars in Oncology 的审稿周期多长?
按 2024年10月至2026年10月(近 24 个月)102 篇已发表文章登记的日期,投稿到接收的中位数为 100 天(四分位 68–144 天);投稿社区反馈的平均审稿速度为6–12 周,平均录用比例反馈为“一般”。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
Seminars in Oncology 的投稿格式要求是什么?
据期刊作者指南:摘要:≤ 250 词;正文篇幅:≤ 6,000 词;参考文献格式:顺序编码制(按引用顺序编号)。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
Seminars in Oncology 的编委会里有中国学者吗?
期刊官网编委会页面上标注了国家的 16 位编委中,中国大陆 5 位(约 31%);人数最多的国家是 美国(11 位)、中国(5 位)。统计按编委会页面列出的机构国家计,仅供参考。
Seminars in Oncology 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Seminars in Oncology 被 SCIE、Scopus 收录。
Seminars in Oncology 是开放获取期刊吗?版面费多少?
Seminars in Oncology 为混合开放获取。选择开放获取发表时APC 约 3,550 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。